BioMarin Pharmaceutical Inc
BMRN· Nasdaq
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Revenue | $227.94M | $229.40M | $146.87M | $131.94M |
| Net Income | $68.62M | -$69.80M |
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
| -$61.99M |
| -$53.01M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.